Document:

d1207423_ex4-15.htm

Exhibit 4.15

 

 

SHARE PURCHASE AGREEMENT

 

SHARE PURCHASE AGREEMENT (the "Agreement"), dated as of June 9, 2011, by and between Diana Containerships Inc., a Marshall Islands Corporation (the "Company"), and Diana Shipping Inc., a Marshall Islands Corporation, (the "Buyer").

 

WHEREAS, the Company is currently conducting a public offering of the Company's common shares, par value $0.01 (the "Shares"), not including any over-allotment that may be exercised by the underwriters, under the Securities Act of 1933, as amended (the "Offering"); and

 

WHEREAS, the Buyer owns approximately 11% of the Company's issued and outstanding common shares prior to the Offering; and

 

WHEREAS, the Company has agreed to issue to the Buyer, and the Buyer has agreed to purchase, $20.0 million United States dollars of the Company's common shares at the same price per share as is being offered to the public in the Offering, before underwriting discounts and commissions (the "Purchased Shares"); and

 

WHEREAS, the Purchased Shares shall be issued and purchased simultaneously with the closing of the Offering (the "Closing").

 

NOW, THEREFORE, in consideration of the mutual covenants herein contained, and for such other good and valuable consideration, the receipt of which is hereby acknowledged, the parties hereto hereby agree as follows:

 

ARTICLE I

 

PURCHASE AND SALE OF SHARES

 

Upon the terms and subject to the conditions of this Agreement:

 

1.1    Issuance and Purchase of Shares. The Company shall issue, set over and deliver to the Buyer, free and clear of all liens and outstanding charges of whatever nature ("Liens"), and the Buyer shall purchase from the Company, the Purchased Shares on the Closing Date.

 

1.2    Purchase Consideration. In consideration for the Purchased Shares, the Buyer shall pay in immediately available funds for the Purchased Shares as follows:

 

(a)    $20.0 million at the Closing.

 

ARTICLE II

 

REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF THE COMPANY

 

The Company hereby represents and warrants to, and agrees with the Buyer, as of the date hereof and the Closing, as follows:

 

2.1    Capacity; Authority; Validity. The Company has all capacity, power and authority to enter into this Agreement and to perform all the obligations to be performed by the Company hereunder; this Agreement and the consummation by the Company of the transactions contemplated hereby and thereby have been duly and validly authorized by all necessary action of the Company; this Agreement has been duly executed and delivered by the Company; and assuming the due execution and delivery of this Agreement by the Buyer, this Agreement constitutes the legal, valid and binding obligation of the Company enforceable against the Company in accordance with their respective terms.

 

2.2    Validity of Shares. Upon delivery of the Purchased Shares by the Company in accordance with the terms of this Agreement, the Purchased Shares shall be duly issued, fully paid and non-assessable, free and clear of all Liens.

 

  

  

  

 

2.3    No Violation of Law or Agreement. Neither the execution and delivery of this Agreement by the Company, nor the consummation of the transactions contemplated hereby by the Company, will violate any judgment, order, writ, decree, law, rule, regulation or agreement applicable to the Company.

 

ARTICLE III

 

REPRESENTATIONS, WARRANTIES AND AGREEMENTS OF BUYER

 

The Buyer hereby represents and warrants to, and agrees with the Company, as of the date hereof and the Closing as follows:

 

3.1    Capacity; Authority; Validity. The Buyer has all necessary capacity, power and authority to enter into this Agreement and to perform all the obligations to be performed by the Buyer hereunder; this Agreement and the consummation by the Buyer of the transactions contemplated hereby have been duly and validly authorized by all necessary action of the Buyer; this Agreement has been duly executed and delivered by the Buyer; and assuming the due execution and delivery of this Agreement by the Company, this Agreement constitutes the legal, valid and binding obligation of the Buyer enforceable against the Buyer in accordance with its terms.

 

3.2    No Violation of Law or Agreement. Neither the execution and delivery of this Agreement by the Buyer, nor the consummation of the transactions contemplated hereby by the Buyer, will violate any judgment, order, writ, decree, law, rule, regulation or agreement applicable to the Buyer or create any Lien over the Buyer's assets.

 

3.3    No Registration. The Buyer understands that the Purchased Shares have not been registered under the Securities Act, are being sold in a transaction that is exempt from the registration requirements of the Securities Act and that the Purchased Shares may not be re-offered or resold except as permitted in the following sentence. The Buyer agrees that it will resell the Purchased Shares only (A) to the Company, its successors or assigns, (B) outside the United States in accordance with Rule 904 of Regulation S under the Securities Act, (C) pursuant to an exemption from registration provided by Rule 144 under the Securities Act or another available exception from registration, or (D) pursuant to an effective registration statement under the Securities Act, and the Buyer further agrees to provide to any person purchasing any of the Purchased Shares from it a notice advising such purchaser that resales of the Purchased Shares are restricted as stated herein. The Buyer understands that any certificates for the Purchased Shares shall carry a restrictive legend to such effect.

 

3.4    Resale. The Buyer understands that, on any proposed resale of the Purchased Shares, it will be required to furnish the Company such certification, legal opinions and other information as the Company may reasonably require to confirm that the proposed sale complies with the foregoing restrictions.

 

ARTICLE IV

 

MISCELLANEOUS

 

4.1    Notices. All notices and other communications by the Buyer or the Company hereunder shall be in writing to the other party and shall be deemed to have been duly given when delivered in person or by an overnight courier service, or sent via telecopy transmission and verification received, or when posted by postal service, registered or certified mail, return receipt requested with postage prepaid, at the address set forth on the signature page hereto or to such other addresses as a party may from time to time designate to the other party by written notice thereof, effective only upon actual receipt.

 

4.2    Assignment. This Agreement shall not be assigned by either party without the other's prior written consent.

 

4.3    Entire Agreement. This Agreement constitutes the entire agreement by the parties hereto and supersedes any other agreement, whether written or oral, that may have been made or entered into between them relating to the matters contemplated hereby.

 

4.4    Amendments and Waivers. This Agreement may be amended, modified, superseded, or canceled, and any of the terms, representations, warranties or covenants hereof may be waived, only by written instrument executed by both of the parties hereto or, in the case of a waiver, by the party waiving compliance.

 

  

  

  

 

4.5    Captions; Counterparts, Execution. The captions in this Agreement are for convenience only and shall not be considered a part of or affect the construction or interpretation of any provision of this Agreement. This Agreement may be executed in one or more counterparts, each of which shall be an original, but all of which together shall constitute one and the same instrument.

 

4.6    Governing Law and Submission to Jurisdiction. This Agreement shall be governed by and construed in accordance with the laws of the State of New York without regard to conflicts of laws principles. Any legal action or proceeding in connection with this Agreement or the performance hereof may be brought in the state and federal courts located in the Borough of Manhattan, City, County and State of New York, and the parties hereby irrevocably submit to the non-exclusive jurisdiction of such courts for the purpose of any such action or proceeding.

 

 

  

  

  

 

IN WITNESS WHEREOF, the Buyer and the Company have caused this Agreement to be duly executed as of the date first above written.

 

 

	  	  	  	  	  	  	  	  	  
	
DIANA CONTAINERSHIPS INC.

	
 

	  	
 

	
DIANA SHIPPING INC.

	  	
  

 

	  	  	  
	
By:

	
 

	
 /s/ Symeon Palios

	
 

	  	
 

	
By:

	
 

	
 /s/ Anastasios Margaronis

	  	
 

	
Name: Symeon Palios

 

	
 

	  	
 

	  	
 

	
Name: Anastasios Margaronis

 

	  	
 

	
Title: Director, Chief Executive Officer and Chairman of the Board

	
 

	  	
 

	  	
 

	
Title: Director and President

 

	  	
  

 

	  	  	  
	  	
 

	
Address: Pendelis 16, 175 64 Palaio Faliro, Athens, Greece

	
 

	  	
 

	  	
 

	
Address: Pendelis 16, 175 64 Palaio Faliro, Athens, Greece

	  	
 

	
Telecopy No.: +30 210 9424975

	
 

	  	
 

	  	
 

	
Telecopy No.: +30 210 9424975kl06031_ex10-1.htm

 

Exhibit 10.1

 

 

	
AMENDMENT OF SOLICITATION/MODIFICATION OF CONTRACT

	
1. CONTRACT ID CODE

N/A

	
PAGE OF PAGES

	
1

	
2

	
2. AMENDMENT/MODIFICATION NO.

Modification 0001

	
3. EFFECTIVE DATE

See Block 16 C

	
4. REQUISITION/PURCHASE REQ. NO

N/A

	
5. PROJECT NO. (if applicable)

N/A

	
6. ISSUED BY

	
CODE

	
N/A

	
7. ADMINISTERED BY (If other than Item 6)

	
       CODE

	
N/A

	
DHHS/ASPR/AMCG

330 Independence Avenue, SW,

Room G640,

Washington, DC  20201

	
     

	
8. NAME AND ADDRESS OF CONTRACTOR (No., street, county, State, and Zip Code)

 

SIGA TECHNOLOGIES, INC.

35 E 62nd Street

New York, NY  10065

 

 

 

	   (X)	
9A. AMENDMENT OF SOLICITATION NO.

	  
	
9B. DATED (SEE ITEM 11)       

 

	  
	     X	
10A. MODIFICATION OF CONTRACT/ORDER NO.

 

HHSO100201100001C

	  
	
CODE:  N/A

 

	
FACILITY CODE:  N/A

	
10B. DATED (SEE ITEM 13)

05/13/2011

	  
	
11. THIS ITEM ONLY APPLIES TO AMENDMENTS OF SOLICITATIONS

	  

 

--- The above numbered solicitation is amended as set forth in item 14.  The hour and date specified for receipt of Offers --- is extended --- is not extended.

Offers must acknowledge receipt of this amendment prior to the hour and date specified in the solicitation or as amended by one of the following methods:

(a) By completing Items 8 and 15, and returning _____ copies of the amendment; (b) By acknowledging receipt of this amendment on each copy of the offer submitted; or (c) By separate letter or telegram which includes a reference to the solicitation and amendment numbers.  FAILURE OF YOUR ACKNOWLEDGMENT TO BE RECEIVED AT THE PLACE DESIGNATED FOR THE RECEIPT OF OFFERS PRIOR TO THE HOUR AND DATE SPECIFIED MAY RESULT IN REJECTION OF YOUR OFFER. If by virtue of this amendment, you desire to change an offer already submitted, such change may be made by telegram or letter, provided each telegram or letter makes reference to the solicitation and this amendment, and is received prior to the opening hour and date specified.

	
12. ACCOUNTING AND APPROPRIATION DATA (If Required)  N/A

	  
	
13. THIS ITEM APPLIES ONLY TO MODIFICATIONS OF CONTRACTS/ORDERS, IT MODIFIES THE CONTRACT/ORDER NO. AS DESCRIBED IN ITEM 14.

	  
	
    (Y)

	
A. THIS CHANGE ORDER IS ISSUED PURSUANT TO: (Specify authority) THE CHANGES SET FORTH IN ITEM 14 ARE MADE IN THE CONTRACT ORDER NO. IN ITEM 10A.

	     X	
FAR 52.243-1 Changes - Fixed Price (AUG 1987)

	 	
B. THE ABOVE NUMBERED CONTRACT/ORDER IS MODIFIED TO REFLECT THE ADMINISTRATIVE CHANGES (such as changes in paying office, appropriation date, etc.) SET FORTH IN ITEM 14, PURSUANT TO THE AUTHORITY OF FAR 43,103 (b).

	 	
C. THIS SUPPLEMENTAL AGREEMENT IS ENTERED INTO PURSUANT TO AUTHORITY OF:

FAR 1.605-1:  Mutual Agreement of all parties

	 	
D. OTHER (Specify type of modification and authority)

     

	
 

E. IMPORTANT: Contractor [X] is not, [ ] is required to sign this document and return   0   copies to the issuing office.

	  

14. DESCRIPTION OF AMENDMENT/MODIFICATION (Organized by UCF section headings, including solicitation/contract subject matter where feasible.)

PURPOSE:  The purpose of this modification is to delete Contract Line Item (CLIN) 14.  The Price Schedule is revised as noted on the continuation sheet.

 

	FUNDS ALLOTTED PRIOR TO MOD #10	$432,885,825.00	 
	FUNDS ALLOTTED WITH MOD #10	$                  0.00	 
	TOTAL FUNDS ALLOTTED TO DATE	$432,885,825.00  	(Unchanged)
	EXPIRATION DATE:	May 12, 2016	(Unchanged)
	CONTRACT FUNDED THROUGH:	May 12, 2016	(Unchanged)

 

	
 

	  
	
Except as provided herein, all terms and conditions of the document referenced in Item 9A or 10A, as heretofore changed, remains unchanged and in full force and effect.

	  
	
15A. NAME AND TITLE OF SIGNER (Type or print)

          

	
16A. NAME AND TITLE OF CONTRACTING OFFICER (Type or print)

      Brian K. Goodger, Contracting Officer  DHHS/ASPR/AMCG

	  
	
15B. CONTRACTOR/OFFEROR

	
15C. DATE  SIGNED

	
16B. UNITED STATES OF AMERICA

BY       /s/ Brian K. Goodger                   

 

	
16C. DATE  SIGNED

    6/24/2011

	
(Signature of person authorized to sign)

	  	
(Signature of Contracting Officer)

	  

NSN 7540-01-152-8070     OMB No. 0990-0115                                       STANDARD FORM 30 (REV. 10-83)

 

 

 

 

  

  

  

 

 

	
Contract No.

HHSO100201100001C

Modification No. 1

	
Continuation Sheet

	
Page 2 of 2

By effect of this Modification 0001, the Contract is revised as follows:

 

1.   Contract Line Item 14 (as seen below) is deleted in entirety from the Contract.

 

	
Option

	  	  	  	  	  
	
CLIN#

	
Cost

Type

	
Supply or Service

	
U/I

	
Qty

	
Unit Price

	
Extended Price

	
0014

	
FFP

	
Purchase of Additional

Treatment Courses (Up to 12

Million).  As described in

Section C.7.5

	
EA

	
TBD

	  	
TBD

2.   The following requirements in Section C are deleted in their entirety:

 

	
C.7.5

	
BARDA may exercise optional CLINs to purchase additional antiviral treatment courses.  (CLIN 0014)

 

	
C.7.5.1

	
The Contractor shall submit a plan and schedule for antiviral drug product manufacture and control at large-scale production and under cGMP compliance to deliver up to an additional 12 million treatment courses

 

	
C.7.5.2.

	
The plan shall provide unit prices as well as cost and price data that support the unit prices (See Section B.8.) offered for the purchase of additional treatment courses using the following increments.  The government shall evaluate the prices as well as the cost or price data as part of its best value analysis prior to award of Base Contract and prior to award of any option orders of treatment courses:

 

All other terms and conditions of Contract HHSO100201100001C remain unchanged.

END OF MODIFICATION 1 TO HHSO100201100001C

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00191-of-00352.parquet"}]]